Differentiating itself by developing innovative drug delivery systems, GeiserPharma has done it again and it has recently received its first Marketing Authorization (MA) of a new innovative pharmaceutical form of its portfolio.

Chewing gums with antibacterial and antiseptic properties indicated for the sore throat relief developed with its Strategic Partner Cafosa “a world reference supplier of gum bases, the main ingredient in chewing gum”.

Geiser Pharma, a company specialized in Research and Development activities, is a clear example of how innovation enables the implementation of advanced technologies which provide added value to the product.

These gums are added to the wide technological offer that could be found in its portfolio: Lozenges, sprays for oral use, capsules, tablets, sachets, syrups and granules among others.

GeiserPharma continues being committed to innovation as a driver of development and value creation.